SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-19-059564
Filing Date
2019-11-04
Accepted
2019-11-04 17:01:51
Documents
69
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q iova-20190930x10q4611ce.htm   iXBRL 10-Q 2099938
2 EX-10.1 ex-10d1.htm EX-10.1 78871
3 EX-10.2 ex-10d2.htm EX-10.2 34755
4 EX-31.1 ex-31d1.htm EX-31.1 14249
5 EX-31.2 ex-31d2.htm EX-31.2 14180
6 EX-32.1 ex-32d1.htm EX-32.1 11009
7 EX-32.2 ex-32d2.htm EX-32.2 8642
13 GRAPHIC ex-10d1g001.jpg GRAPHIC 16107
14 GRAPHIC iova-20190930x10q4611ce002.jpg GRAPHIC 53914
  Complete submission text file 0001104659-19-059564.txt   7882011

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA iova-20190930.xsd EX-101.SCH 45340
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE iova-20190930_cal.xml EX-101.CAL 37420
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE iova-20190930_def.xml EX-101.DEF 206824
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE iova-20190930_lab.xml EX-101.LAB 369310
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iova-20190930_pre.xml EX-101.PRE 342465
40 EXTRACTED XBRL INSTANCE DOCUMENT iova-20190930x10q4611ce_htm.xml XML 1407303
Mailing Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070
Business Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36860 | Film No.: 191190601
SIC: 2836 Biological Products, (No Diagnostic Substances)